157 related articles for article (PubMed ID: 21422248)
1. Convergence of the mammalian target of rapamycin complex 1- and glycogen synthase kinase 3-β-signaling pathways regulates the innate inflammatory response.
Wang H; Brown J; Gu Z; Garcia CA; Liang R; Alard P; Beurel E; Jope RS; Greenway T; Martin M
J Immunol; 2011 May; 186(9):5217-26. PubMed ID: 21422248
[TBL] [Abstract][Full Text] [Related]
2. Glycogen synthase kinase 3 signaling in neural regeneration in vivo.
Zhang J; Yang SG; Zhou FQ
J Mol Cell Biol; 2024 Apr; 15(12):. PubMed ID: 38059848
[TBL] [Abstract][Full Text] [Related]
3. mTORC1-dependent translation of collapsin response mediator protein-2 drives neuroadaptations underlying excessive alcohol-drinking behaviors.
Liu F; Laguesse S; Legastelois R; Morisot N; Ben Hamida S; Ron D
Mol Psychiatry; 2017 Jan; 22(1):89-101. PubMed ID: 26952865
[TBL] [Abstract][Full Text] [Related]
4. Glycogen synthase kinase 3-β inhibition induces lymphangiogenesis through β-catenin-dependent and mTOR-independent pathways.
Stump B; Shrestha S; Lamattina AM; Louis PH; Cho W; Perrella MA; Ai X; Rosas IO; Wagner FF; Priolo C; Astin J; El-Chemaly S
PLoS One; 2019; 14(4):e0213831. PubMed ID: 30964887
[TBL] [Abstract][Full Text] [Related]
5. Salmonella Effector SteE Converts the Mammalian Serine/Threonine Kinase GSK3 into a Tyrosine Kinase to Direct Macrophage Polarization.
Panagi I; Jennings E; Zeng J; Günster RA; Stones CD; Mak H; Jin E; Stapels DAC; Subari NZ; Pham THM; Brewer SM; Ong SYQ; Monack DM; Helaine S; Thurston TLM
Cell Host Microbe; 2020 Jan; 27(1):41-53.e6. PubMed ID: 31862381
[TBL] [Abstract][Full Text] [Related]
6. A review of Glycogen Synthase Kinase-3 (GSK3) inhibitors for cancers therapies.
Thapa R; Gupta G; Bhat AA; Almalki WH; Alzarea SI; Kazmi I; Saleem S; Khan R; Altwaijry N; Dureja H; Singh SK; Dua K
Int J Biol Macromol; 2023 Dec; 253(Pt 7):127375. PubMed ID: 37839597
[TBL] [Abstract][Full Text] [Related]
7. Coordinate control of host centrosome position, organelle distribution, and migratory response by Toxoplasma gondii via host mTORC2.
Wang Y; Weiss LM; Orlofsky A
J Biol Chem; 2010 May; 285(20):15611-15618. PubMed ID: 20236941
[TBL] [Abstract][Full Text] [Related]
8. Glycogen synthase kinase-3 (GSK3) in psychiatric diseases and therapeutic interventions.
Jope RS; Roh MS
Curr Drug Targets; 2006 Nov; 7(11):1421-34. PubMed ID: 17100582
[TBL] [Abstract][Full Text] [Related]
9. Underlying mechanisms of glucocorticoid-induced β-cell death and dysfunction: a new role for glycogen synthase kinase 3.
Delangre E; Liu J; Tolu S; Maouche K; Armanet M; Cattan P; Pommier G; Bailbé D; Movassat J
Cell Death Dis; 2021 Dec; 12(12):1136. PubMed ID: 34876563
[TBL] [Abstract][Full Text] [Related]
10. Stressed and Inflamed, Can GSK3 Be Blamed?
Jope RS; Cheng Y; Lowell JA; Worthen RJ; Sitbon YH; Beurel E
Trends Biochem Sci; 2017 Mar; 42(3):180-192. PubMed ID: 27876551
[TBL] [Abstract][Full Text] [Related]
11. Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics.
Jope RS; Yuskaitis CJ; Beurel E
Neurochem Res; 2007; 32(4-5):577-95. PubMed ID: 16944320
[TBL] [Abstract][Full Text] [Related]
12. Convergent genomic and pharmacological evidence of PI3K/GSK3 signaling alterations in neurons from schizophrenia patients.
Stertz L; Di Re J; Pei G; Fries GR; Mendez E; Li S; Smith-Callahan L; Raventos H; Tipo J; Cherukuru R; Zhao Z; Liu Y; Jia P; Laezza F; Walss-Bass C
Neuropsychopharmacology; 2021 Feb; 46(3):673-682. PubMed ID: 33288841
[TBL] [Abstract][Full Text] [Related]
13. In silico anti-alzheimer study of phytochemicals from Lamiaceae family through GSK3-β inhibition.
Zareei S; Pourmand S; Eskandarzadeh M; Massahi S
Sci Rep; 2024 Jan; 14(1):834. PubMed ID: 38191548
[TBL] [Abstract][Full Text] [Related]
14. Suppression of nuclear GSK3 signaling promotes serine/one-carbon metabolism and confers metabolic vulnerability in lung cancer cells.
He L; Endress J; Cho S; Li Z; Zheng Y; Asara JM; Blenis J
Sci Adv; 2022 May; 8(20):eabm8786. PubMed ID: 35594343
[TBL] [Abstract][Full Text] [Related]
15. Somatostatin-SSTR3-GSK3 modulates human T-cell responses by inhibiting OXPHOS.
Zhang B; Feng H; Lin H; Li R
Front Immunol; 2024; 15():1322670. PubMed ID: 38426092
[TBL] [Abstract][Full Text] [Related]
16. GSK3 as a Master Regulator of Cellular Processes.
Lichtinghagen R; Huber R
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958485
[TBL] [Abstract][Full Text] [Related]
17. α7 Nicotinic acetylcholine receptor: a key receptor in the cholinergic anti-inflammatory pathway exerting an antidepressant effect.
Liu H; Zhang X; Shi P; Yuan J; Jia Q; Pi C; Chen T; Xiong L; Chen J; Tang J; Yue R; Liu Z; Shen H; Zuo Y; Wei Y; Zhao L
J Neuroinflammation; 2023 Mar; 20(1):84. PubMed ID: 36973813
[TBL] [Abstract][Full Text] [Related]
18. Emerging targets signaling for inflammation in Parkinson's disease drug discovery.
Khairnar RC; Parihar N; Prabhavalkar KS; Bhatt LK
Metab Brain Dis; 2022 Oct; 37(7):2143-2161. PubMed ID: 35536461
[TBL] [Abstract][Full Text] [Related]
19. Sepsis-associated brain injury: underlying mechanisms and potential therapeutic strategies for acute and long-term cognitive impairments.
Sekino N; Selim M; Shehadah A
J Neuroinflammation; 2022 Apr; 19(1):101. PubMed ID: 35488237
[TBL] [Abstract][Full Text] [Related]
20. mTOR Signaling Pathway Regulates the Release of Proinflammatory Molecule CCL5 Implicated in the Pathogenesis of Autism Spectrum Disorder.
Wang B; Qin Y; Wu Q; Li X; Xie D; Zhao Z; Duan S
Front Immunol; 2022; 13():818518. PubMed ID: 35422816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
